Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells-Reference-Cited by-同舟云学术

Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells

Published:2011-01 Issue:1 Volume:46 Page:433-438
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Marrazzo Agostino,Fiorito Jole,Zappalà Laura,Prezzavento Orazio,Ronsisvalle Simone,Pasquinucci Lorella,Scoto Giovanna M.,Bernardini Renato,Ronsisvalle Giuseppe

Funder

FIRB 2003

PRIN 2005 and 2007

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Epigenetics of prostate cancer

2. Androgens and prostate cancer

3. Downregulation of Thymosin 4 Expression by Androgen in Prostate Cancer LNCaP Cells

4. Targeted therapeutic approaches for hormone-refractory prostate cancer

5. Novel targets and approaches in advanced prostate cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors;Molecules;2024-06-06

2. Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity;Bioorganic Chemistry;2023-11

3. Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate;International Journal of Biological Macromolecules;2023-03

4. Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects;Bioorganic & Medicinal Chemistry;2022-11

5. Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate;2022-07-13